Companies / Metrion Biosciences
Metrion Biosciences
Company
Metrion Biosciences provides preclinical drug discovery services, including ion channel screening, cardiac safety screening, and neuroscience services.
Metrion Biosciences has 2 investors on file, among them Gresham House Ventures and o2h Ventures. Its site was last checked 6 Nov 2026: site answers.
Investors
2 investors on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Venture capital | |
| Portfolio page | Venture capital |
More from Gresham House Ventures
73 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (16%), Fintech (13%), E-commerce & Marketplaces (10%).
See Gresham House Ventures' full profile · Who invests alongside it
More from o2h Ventures
36 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (94%), Enterprise Software (3%), AI & Machine Learning (3%).
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get Metrion Biosciences and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Gresham House Ventures adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/metrionbiosciences.com/investors
# also
GET /v1/companies/metrionbiosciences.com
GET /v1/companies/metrionbiosciences.com/news